REQUEST A DEMO
Total
USD $0.00
Search more companies

Novmetapharma Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Novmetapharma Co. Ltd. Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the development and sale of pharmaceuticals. The Company operates its business through two segments. The New Drug Development segment is involved in the development and sale of diabetes treatment, obesity treatment, osteoporosis treatment, alzheimer s disease treatment, and autoimmune enhancers. The Health Functional Food segment is engaged in the manufacturing and sale of health functional food related to blood sugar, prostate health, comprehensive minerals, and cognitive improvement. It also produces and sells vinegar drinks. The Company distributes its products within the domestic market and to overseas markets, including America and China. The Company was founded on Novembe 04 , 2010. and its shares are listed on KOREA NEW EXCHANGE(KONEX) on October 28, 2015.

Headquarters
Trees Bldg., 727, Eonju-Ro, Gangnam-Gu
Seoul; Seoul;

Contact Details: Purchase the Novmetapharma Co. Ltd. report to view the information.

Website: http://www.novmeta.com

Basic Information
Total Employees:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Novmetapharma Co. Ltd. report to view the information.
Incorporation Date:
2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
주식회사 노브메타헬스
55.6%
Company Performance
Financial values in the chart are available after Novmetapharma Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-56%
Total operating revenue
-67.7%
Operating profit (EBIT)
-4.47%
EBITDA
-4.69%
Net Profit (Loss) for the Period
-104.4%
Total assets
148.15%
Total equity
N/A
Operating Profit Margin (ROS)
-32484.1%
Net Profit Margin
-71132.49%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
N/A
Quick Ratio
2.04%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?